Practical considerations to establish a validated platform for pooled detection of SARS-CoV-2 by droplet digital PCR

dc.citation.titlePLoS ONEes
dc.citation.volume17
dc.creatorHeckel, Sofía
dc.creatorPacini, Antonella
dc.creatorParedes, Franco
dc.creatorPetreli, María Victoria
dc.creatorPerez, Marilina
dc.creatorAdriani, Natalia
dc.creatorIbarra, Guadalupe
dc.creatorMenzella, Hugo G.
dc.creatorColaneri, Alejandro
dc.creatorSesma, Juliana
dc.date.accessioned2023-02-09T18:44:20Z
dc.date.available2023-02-09T18:44:20Z
dc.date.issued2022-11-04
dc.descriptionDetection of SARS-CoV-2 has created an enormous workload for laboratories worldwide resulting in a restriction at the time of massive testing. Pool testing is a strategy that reduces time and costs. However, beyond the detection of infectious diseases in blood banks, this approach is rarely implemented in routine laboratories. Therefore, what was learned from the SARS-CoV-2 pool testing should represent an opportunity to increase diagnostic capabilities. The present work, carried out in the context of a diagnostic laboratory of a public hospital during the COVID-19 pandemic, represents a contribution to this end. The main limitation of pool testing is the risk of false negatives that could have been identified by individual tests. These limitations are the dilution of samples with a low virus load during pooling and that the integrity of the sample may be affected by the quality of the sample collection. Fortunately, both limitations coincide with the main strengths of droplet digital PCR (ddPCR). ddPCR is a third-generation PCR that splits the amplification into thousands of droplets that work in parallel, increasing sensitivity and resistance to inhibitors. Therefore, ddPCR is particularly useful for pool testing. Here we show how to factor between test sensitivity and savings in test time and resources. We have identified and optimized critical parameters for pool testing. The present study, which analyzed 1000 nasopharyngeal samples, showed that the pool testing could detect even a single positive sample with a CT value of up to 30 in pools of 34 samples. This test was performed using three different standard extraction methods, the simplest being heating only, which resulted in substantial savings of extraction reagents in addition to PCR reagents. Moreover, we show that pooling can be extended to use saliva, which is less invasive and allows self-collection, reducing the risk for health personnel.es
dc.descriptionHeckel S, Pacini A, Paredes F, Petreli M.V, Perez M, Adriani N, et al. (2022) Practical considerations to establish a validated platform for pooled detection of SARS-CoV-2 by droplet digital PCR. PLoS ONE 17(11): e0271860. https://doi.org/ 10.1371/journal.pone.0271860
dc.description.filFil: Heckel, Sofía. Hospital Provincial de Rosario. Molecular Biology Department; Argentina.es
dc.description.filFil: Heckel, Sofía. Instituto de Inmunología Clínica y Experimental de Rosario (IDICER-CONICET); Argentina.es
dc.description.filFil: Heckel, Sofía. Instituto de Procesos Biotecnológicos y Químicos Rosario (IPROByQ); Argentina.es
dc.description.filFil: Pacini, Antonella. Hospital Provincial de Rosario. Molecular Biology Department; Argentina.es
dc.description.filFil: Pacini, Antonella. Instituto de Inmunología Clínica y Experimental de Rosario (IDICER-CONICET); Argentina.es
dc.description.filFil: Paredes, Franco. Hospital Provincial de Rosario. Molecular Biology Department; Argentina.es
dc.description.filFil: Paredes, Franco. Instituto de Procesos Biotecnológicos y Químicos Rosario (IPROByQ); Argentina.es
dc.description.filFil: Petreli, María Victoria. Hospital Provincial de Rosario. Molecular Biology Department; Argentina.es
dc.description.filFil: Petreli, María Victoria. Instituto de Procesos Biotecnológicos y Químicos Rosario (IPROByQ); Argentina.es
dc.description.filFil: Perez, Marilina. Hospital Provincial de Rosario. Molecular Biology Department; Argentina.es
dc.description.filFil: Adriani, Natalia. Hospital Provincial de Rosario. Molecular Biology Department; Argentina.es
dc.description.filFil: Ibarra, Guadalupe. Hospital Provincial de Rosario. Molecular Biology Department; Argentina.es
dc.description.filFil: Ibarra, Guadalupe. Instituto de Procesos Biotecnológicos y Químicos Rosario (IPROByQ); Argentina.es
dc.description.filFil: Menzella, Hugo G. Instituto de Procesos Biotecnológicos y Químicos Rosario (IPROByQ); Argentina.es
dc.description.filFil: Menzella, Hugo G. Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET); Argentina.es
dc.description.filFil: Colaneri, Alejandro. Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET); Argentina.es
dc.description.filFil: Sesma, Juliana. Hospital Provincial de Rosario. Molecular Biology Department; Argentina.es
dc.description.filFil:. Sesma, Juliana. Instituto de Inmunología Clínica y Experimental de Rosario (IDICER-CONICET); Argentina.es
dc.description.filFil: Sesma, Juliana. Universidad Nacional de Rosario. Facultad de Ciencias Médicas; Argentina.es
dc.formatapplication/pdf
dc.format.extent1-14es
dc.identifier.issn1932-6203es
dc.identifier.urihttp://hdl.handle.net/2133/25149
dc.language.isoenges
dc.publisherPublic Library of Sciencees
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0271860
dc.relation.publisherversionhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0271860#references
dc.rightsopenAccesses
dc.rights.holderHeckel, Sofíaes
dc.rights.holderPacini, Antonellaes
dc.rights.holderParedes, Francoes
dc.rights.holderPetreli, María Victoriaes
dc.rights.holderPerez, Marilinaes
dc.rights.holderAdriani, Nataliaes
dc.rights.holderIbarra, Guadalupees
dc.rights.holderMenzella, Hugo G.es
dc.rights.holderColaneri, Alejandroes
dc.rights.holderSesma, Julianaes
dc.rights.holderUniversidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas
dc.rights.textAttribution 4.0 International (CC BY 4.0)es
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19es
dc.subjectPandemicses
dc.subjectReal-time polymerase chain reactiones
dc.subjectSARS-CoV-2es
dc.subjectCOVID-19 testinges
dc.subjectSensitivity and specificityes
dc.subjectSpecimen handlinges
dc.titlePractical considerations to establish a validated platform for pooled detection of SARS-CoV-2 by droplet digital PCRes
dc.typearticle
dc.typeartículo
dc.typepublishedVersion
dc.type.collectionarticulo
dc.type.versionpublishedVersiones

Archivos

Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Practical considerations to establish a validated platform for pooled detection of SARS-CoV-2 by droplet digital PCR.pdf
Tamaño:
775.87 KB
Formato:
Adobe Portable Document Format
Descripción:
Bloque de licencias
Mostrando 1 - 1 de 1
Nombre:
license.txt
Tamaño:
3.59 KB
Formato:
Item-specific license agreed upon to submission
Descripción: